Skip to main content

Table 5 Ki67 expression and change value of CNB and SRS among molecular subtypes

From: Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients

 

No.

Median Ki67 (IQR)

Mean Ki67(SD)

Luminal A

73

  

  CNB

 

10 (5, 10)

8.2 (4.1)

  SRS

 

10 (10, 20)

14.5 (9.6)

  Ki67 changea

 

5 (0, 10)

6.3 (8.6)

Luminal B HER2-

109

  

  CNB

 

20 (10, 40)

26.9 (19.5)

  SRS

 

20 (10, 30)

26.9 (19.2)

  Ki67 changea

 

0 (-10, 10)

-0.1 (12.8)

Luminal B HER2+

33

  

  CNB

 

20 (10, 50)

30.2 (20.7)

  SRS

 

30 (15, 55)

33.5 (20.0)

  Ki67 changea

 

0 (-10, 14.5)

3.3 (15.1)

Triple negative

35

  

  CNB

 

60 (30, 80)

54.1 (26.4)

  SRS

 

70 (30, 80)

57.4 (25.8)

  Ki67 changea

 

0 (-10, 10)

3.3 (13.5)

HER2 positive

26

  

  CNB

 

25 (20, 40)

31.2 (17.3)

  SRS

 

30 (23.75, 50)

35.4 (15.1)

  Ki67 changea

 

5 (-1.25, 20.0)

4.2 (19.6)

  1. aKi67 change, SRS minus CNB
  2. Abbreviation: CNB core needle biopsy, IQR inter quartile range, SRS surgically removed samples, SD standard deviation